R. Michael Carruthers - May 23, 2022 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Chief Financial Officer
Signature
/s/ John R. Moore Attorney-in-Fact for R. Michael Carruthers
Stock symbol
EWTX
Transactions as of
May 23, 2022
Transactions value $
$0
Form type
4
Date filed
5/25/2022, 06:11 PM
Previous filing
May 3, 2022
Next filing
Jun 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EWTX Common Stock Options Exercise $6.39K +9K +300% $0.71* 12K May 23, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EWTX Stock Option (Right to Buy) Options Exercise -$6.39K -9K -4.16% $0.71* 207K May 23, 2022 Common Stock 9K $0.71 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,562 shares purchased on November 15, 2021 and 1,438 shares purchased on May 15, 2022 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan.
F2 1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date.